TSHA icon

Taysha Gene Therapies
TSHA

Overview Fund Activity

48 hedge funds and large institutions have $388M invested in Taysha Gene Therapies in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
26
Reduced
5
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
$62.9M
2
NCM
Nantahala Capital Management
Connecticut
$9.16M
3
TCM
TimesSquare Capital Management
New York
$14.5M
4
State Street
State Street
Massachusetts
$6.76M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$4.53M

Top Sellers

1
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$29.5M
2
CC
Casdin Capital
New York
$0
3
PA
Perceptive Advisors
New York
$6.79M
4
VA
VR Adviser
New York
$0
5
ACH
ArrowMark Colorado Holdings
Colorado
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ACH
51
ArrowMark Colorado Holdings
Colorado
– -$2.35M -115,723 Closed
Wells Fargo
52
Wells Fargo
California
– -$1.17M -57,412 Closed
Alyeska Investment Group
53
Alyeska Investment Group
Illinois
– -$508K -25,000 Closed
HF
54
HRT Financial
New York
– -$248K -12,239 Closed
SO
55
STRS Ohio
Ohio
– -$42K -2,100 Closed
Bank of Montreal
56
Bank of Montreal
Ontario, Canada
– -$5K -268 Closed
1 2
3